SciELO - Scientific Electronic Library Online

vol.25 issue12The science of collective health in writing: contribution to studies in collective oral healthPrimary care experiences in 25 years of Journal Ciência & Saúde Coletiva: a review of the scientific literature author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Ciência & Saúde Coletiva

Print version ISSN 1413-8123On-line version ISSN 1678-4561

Ciênc. saúde coletiva vol.25 no.12 Rio de Janeiro Dec. 2020  Epub Dec 04, 2020 


An ontology of Pharmaceutical Services in the pages of Journal Ciência & Saúde Coletiva

Claudia Garcia Serpa Osorio-de-Castro1

Tatiana de Jesus Nascimento Ferreira1

Mario Jorge Sobreira da Silva2

Elaine Silva Miranda3

Cristiane Roberta dos Santos Teodoro4

Elaine Lazzaroni Moraes2

Elisangela da Costa Lima5

Cláudia Du Bocage Santos-Pinto6

1Departamento de Política de Medicamentos e Assistência Farmacêutica, Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz. R. Leopoldo Bulhões 1480, Manguinhos. 21041-210 Rio de Janeiro RJ Brasil.

2Instituto Nacional do Câncer José Alencar Gomes da Silva. Rio de Janeiro RJ Brasil.

3Departamento de Farmácia e Administração Farmacêutica, Faculdade de Farmácia, Universidade Federal Fluminense. Niterói RJ Brasil.

4Instituto de Psiquiatria, Universidade Federal do Rio de Janeiro (UFRJ). Rio de Janeiro RJ Brasil.

5Faculdade de Farmácia, UFRJ. Rio de Janeiro RJ Brasil.

6Instituto Integrado de Saúde, Universidade Federal de Mato Grosso do Sul. Campo Grande MS Brasil.


Pharmaceutical Services (PS) is a growing field which has established itself over the last 25 years in Brazil through scientific publications. This work investigates the evolution of the field in the Brazilian periodical Journal Ciência & Saúde Coletiva. We conducted a scoping review of relevant literature produced in four separate periods (1996-2003, 2004-2010, 2011-2015, and 2016-2019). A search for articles that contained one or more of the pre-established key words in the title was performed by separate pairs of reviewers. The search resulted in 307 articles, 260 of which were included. The findings show that the number of publications increased steadily over the study period. The papers were predominantly open-topic and original articles and written in Portuguese. Most of the lead authors were from the South and Southeastern regions of Brazil and from public universities and Fiocruz. The predominant primary theme was medicine utilization (161 articles), followed by management (56), and tangential aspects of the PM cycle (43). An ontology of PS was created based on the classification of the articles. The findings show that the field of PS encompasses public policy and management and frontline activities involved in the delivery of health care to the population. It is hoped that the diverse range of interrelations in the field of PS will be increasingly addressed in future publications.

Key words: Pharmaceutical Services; Publications; Review


A Assistência Farmacêutica (AF) é um campo em expansão no Brasil e nos últimos 25 anos vem se consolidando também através da publicação científica. O objetivo deste trabalho foi investigar a evolução da AF como campo na Revista Ciência & Saúde Coletiva. Uma revisão de escopo, em quatro períodos, 1996-2003, 2004-2010, 2011-2015, 2016-2019, foi realizada por duplas de pesquisadores, buscando palavras e termos de busca nos títulos. As inclusões foram totalizadas por ano de publicação, suas características descritas quanto ao tipo de artigo, idioma, local e instituição de origem do primeiro autor e classificadas por temáticas principais, secundárias e especificidades. Foram resgatados 307 artigos e incluídos 260. Os resultados refletiram aumento de publicações ao longo do tempo, participação majoritária de artigos de tema livre e originais, em português, de autores das regiões Sul e Sudeste, de universidades públicas e da Fiocruz. Os temas principais foram Utilização de Medicamentos (161 artigos), Gestão (56) e Temas Tangenciais ao Ciclo da AF (43). A partir da classificação foi elaborada uma ontologia própria da AF. O campo reúne política pública a atividades gerenciais e de cuidados em saúde à população. Espera-se que essa variada gama de interrelações venha a se expressar cada vez mais na publicação científica.

Palavras-chave: Assistência Farmacêutica; Publicações; Revisão


Pharmaceutical Services (PS) is a relatively recent field within the pharmaceutical sciences, which has traditionally been shaped by the so-called basic sciences, such as physics, chemistry, biochemistry, and physiology. In turn, the basic sciences characterized the way in which pharmacy was taught and, consequently, the profile of professionals working in academia and care services. Over recent decades, social issues linked to medication have gained greater importance, given that the natural sciences on their own are not capable of explaining or delving deep into aspects that involve relationships between medication and individuals, families, communities, or indeed professional practice1,2.

Brazil’s Organic Health Law, which regulates public health services and actions, provides that one of the fields of action of the country’s public health care system, o Sistema Único de Saúde (SUS) or Unified Health System, is the formulation of the national medicines policy, and states that the health sector shall be responsible for executing comprehensive therapeutic care actions, including pharmaceutical services3. However, PS in Brazil only came to gain a clearer delineation with the introduction of the National Medicines Policy (NMP) in 19984. With regard to the public management of medicines, in 1999 the government embarked on a process to decentralize PS5, defining the responsibilities of each level of management as follows: federal - policy formulation and implementation; state - policy coordination, implementation, monitoring, and evaluation; and local - service provision3.

Another milestone was the creation of the National Pharmaceutical Services Policy (PNPS, acronym in Portuguese) in 2004, which states that the professional activities of pharmacy professionals in the field of PS include health promotion, protection, and recuperation. It also provides guidelines for the development of PS in terms of innovation and the production of medicines and supplies, promoting the inclusion of PS in the 2004 National Agenda of Priorities for Health Research6.

With the incorporation of PS into the framework of the NMP, an organizational model called the pharmaceutical management cycle (PM cycle) was adopted. Developed in the middle of the 1990s by Management Sciences for Health7, this milestone has been revisited over time to reflect changes in the field that have an impact on the organization of PS activities8. Three core activities are particularly relevant to the PM cycle: tangential activities that precede the cycle, involving actors outside the field of PS; management; and activities related to medicine utilization9.

It is to be expected that scientific output reflects political, normative, and technical frameworks, not only in key moments in the development of the field, but also in relation to the technical maturation of the area and involvement of professionals. An integral part of public health, PS is in its essence the articulation of knowledge tied to practices in health services. Although it encompasses various disciplines from the pharmaceutical sciences, the field is strongly influenced by the social sciences10. The literature has highlighted important changes in PS over time, reflecting on core themes and the role of PS in the SUS11.

Assuming that major public health issues are present in the discussion of this field and its evolution in Brazil, this article analyzes the literature on PS published in the pages of the Journal Ciência & Saúde Coletiva (C&SC) and proposes a first-of-its-kind ontology of PS in Brazil.


We conducted a scoping review of PS in the C&SC12,13. The review period (1996 to 2019) was divided into four time blocks circumscribed by important policies in the area of PS4-6,14-20 and volume of publications, as follows: 1996-2003, 2004-2010, 2011-2015, and 2016-2019.

A pair of researchers were responsible for conducting the search for relevant articles in each time block. The identification of articles was initially carried out independently by each pair member and then in consensus between the pairs and review team to clear up any doubts and detect inconsistencies.

A search was conducted of each issue of the Journal on the C&SC’s website, selecting articles that contained one or more of the following keywords in the title: assistência farmacêutica (pharmaceutical services), medicamentos (medicines), política de medicamentos (medicines policy), farmacêuticos (pharmaceuticals), setor farmacêutico (pharmaceuticals sector), indústria farmacêutica (pharmaceuticals industry), and farmácia hospitalar (hospital pharmacy). The full-text versions of the identified articles were then downloaded using the SciELO link on C&SC’s website and the abstracts were read to check for the keywords mentioned above.

The selected articles were then assessed for eligibility by reading the full-text version. Articles that addressed themes not directly related to PS or medication therapy were excluded, resulting in the final sample of articles for review.

The following information was extracted from the articles: year of publication, author(s), lead author’s affiliation and place of origin, Digital Object Identifier (DOI), section of the publication, type of article, abstract, and keywords. The articles were organized sequentially in a database.

For the analysis, the articles were described in chronological order, presenting the article number, author(s), lead author’s affiliation and place of origin, language in which the paper was published, and type of article. For the purposes of thematic analysis, the articles were grouped according to primary themes, secondary themes, and specific topics based the conceptual framework for pharmaceutical services described in the literature8,9,21: primary theme (tangential aspects of the PM cycle, management, and medicine utilization), secondary theme (an aspect of the primary theme constituting an activity, normative guideline, or conceptual discussion), and specific topics (an underlying topic that reflects the object or locus of the investigation). The dependency relations between the primary themes, secondary themes, and specific topics were also highlighted, thus creating an ontology of PS in the pages of the C&SC.


The search by title yielded 307 articles (Figure 1). The reading of the abstracts resulted in the exclusion of 47 papers addressing topics not directly related to PS: health policy, health spending, health resource allocation, health funding, health care, diagnostics, toxicology, medical practices, medicalization (not related to medication therapy), smoking, illicit drug use, non-medical contraceptive practices, medical and hospital supplies, non-drug therapies, quality of life, and nutrient supplementation. This stage resulted in a final sample of 260 articles (Chart 1).

Chart 1 Selected articles for analysis of the theoretical-practice field of Pharmaceutical Services in the pages of Journal Ciência & Saúde Coletiva, 1996-2019. C&SC, 2020. 

Number Year Language Study site (state or country) or Origin First author Title Journal section
1 1999 POR SP Noto, AR Use and prevention of psychotropic drugs in Brazil Review
2 1999 POR MS Castro, LLC Pharmacoepidemiology in Brazil: evolution and prospects Opinion
3 2002 POR PE Barros, JAC Drug advertisements in medical journals: promoting good prescription? Original Research
4 2003 POR SC Leite, SN Adherence to prescribed therapy: points for concepts and presuppositions discussion Review
5 2003 POR RJ Silva, LK Technology assessment and cost-effectiveness analysis in health care: the adoption of technologies and the development of clinical guidelines for the Brazilian national system Original Research
6 2004 POR SP Pereira, LRL Evaluation of using medicines in elderly subjects through the concepts of pharmacovigilance and pharmacoepidemiology Free Theme
7 2004 POR RJ Osorio-de-Castro, CGS The use of drugs in pregnancy Free Theme
8 2005 POR RJ Nascimento, MC Drugs, communication, and culture Original Research
9 2005 POR SP Secoli, SR Pharmacoeconomics: resultant perspective of decisions process Original Research
10 2007 POR DF Fagundes, MJD Bioethical analysis of drugs advertisement and publicity Free Theme
11 2007 POR PR Melo, EB Description of attempts to obtain approval for selling medications at ordinary Brazilian establishments after the introduction of the Real Economic Stabilization Plan Opinion
12 2007 POR RJ Neves, BG Perceptions and attitudes among parents and guardians on the use of pediatric medicines and their cariogenic and erosive potential Original Research
13 2008 POR DF Bortolon, PC Analysis of the self-medication pattern among Brazilian elderly women Original Research
14 2008 POR RJ Costa-Couto, MH Asymmetry in international relations, industrial property rights and anti-HIV medications Original Research
15 2008 POR MG Abrantes, PM The quality of antibiotics prescription in public health services of Belo Horizonte, MG Original Research
16 2008 POR RJ Alves, NDC Assessment of the technical adequacy of phytotherapeutics and officinal medicine manufacturers in the State of Rio de Janeiro Original Research
17 2008 POR MG Angonesi, D Pharmaceutical dispensing: an analysis of different concepts and models Original Research
18 2008 POR PE Aquino, DS Why rational drug use must be a priority? Original Research
19 2008 POR MG Araújo, ALA Pharmacist care in the Brazilian Primary Health Care System Original Research
20 2008 SPN MG Barros, JAC New tendencies in medicalization Original Research
21 2008 POR RJ Rozenfeld, S The pharmacist: health professional and citizen Debate
22 2008 POR MG Barros, JAC Comments on the text "The pharmacist: health professional and citizen" Debate
23 2008 POR SP Bergsten-Mendes, G Rational use of medicines: the pivotal role of the pharmacist Debate
24 2008 POR RJ Osorio-de-Castro, CGS Accountability makes pharmacists responsible health professionals and citizens Debate
25 2008 POR RJ Elda Falqueto, E Management of residues deriving from the manufacture and distribution of Diazepam in the city of São Mateus, ES Original Research
26 2008 POR SP Fleith, VD Pattern of medicine consumption among users of the primary health care services in Lorena, SP Original Research
27 2008 POR SP Huertas, MKZ Rational and emotional appeals in prescription drug advertising: study of a weight loss drug Original Research
28 2008 POR SC Kulkamp, IC The perception of health professionals about pain management and opioid use: a qualitative study Original Research
29 2008 POR DF Mota, DM Rational drug use: an economic approach to decision making Original Research
30 2008 POR SP Nicolini, P Factors related to prescriptions of antibiotics in a public pharmacy in the Western region of the city of São Paulo Original Research
31 2008 POR RJ Cristiane Quental, C Generic drugs in Brazil: impacts of public policies upon the national industry Original Research
32 2008 POR DF Reis, AMM Drug shortage: determinants, consequences and management Original Research
33 2008 POR DF Carvalho, PB Labeling of vitamin and mineral supplements: a revision of the federal normative regulations Review
34 2008 POR SC Leite, SN Drug utilization studies: a synthesis of articles published in Brazil and Latin America Review
35 2008 POR RJ Loyola, MA Drugs, health policy and AIDS: changes in a dependent policy Review
36 2008 POR RS Rocha, CH Medication adherence of elderly in Porto Alegre, RS Original Research
37 2008 POR PE Silva, RA Factors associated with self-medication for toothache: analysis using pharmacy personnel in the city of Recife, PE Original Research
38 2008 POR RJ Soares, JCRS "When the ad is good, the product is sold." The MonitorAÇÃO Project and drug advertising in Brazil Original Research
39 2008 POR RS Vitor, RS Pattern of drug consumption without medical prescription in the city of Porto Alegre, RS Original Research
40 2008 ENG/POR RJ Rozenfeld, S Medicines, professionals and health care services Editorial
41 2008 POR MT Reiners, AAO Bibliographic production about adherence/non-adherence to therapy Review
42 2009 ENG/POR RJ Nascimento, AC Medication advertising in Brazil. Can it be regulated? Original Research
43 2009 ENG RJ Emmerick, ICM Pharmaceutical services evaluation in Brazil: broadening the results of a WHO methodology Free Theme
44 2010 POR DF Polejack, L Monitoring and evaluation of adherence to ARV treatment for HIV/aids: challenges and possibilities Original Research
45 2010 POR RS Rodrigues, FA The profile of antimicrobial utilization in a private hospital Original Research
46 2010 POR CE Torres, DVM Enfuvirtide in the treatment of AIDS patient: the turning point Free Theme
47 2010 POR RJ Falqueto, E How to do the correct discard of medicine residues? Free Theme
48 2010 POR MG Angonesi, D Pharmaceutical Care: conceptual and critical basis to a Brazilian model Free Theme
49 2010 POR RJ Bastos, CRG The pharmacist's perceptions about their job at communitarian pharmacies of the state of Rio de Janeiro Free Theme
50 2010 POR SP Cintra, FA Medicine adeshion in eldery people in an ambulatorial attendance Free Theme
51 2010 POR DF Gava, CM New medicines registered in Brazil: can they be considered as a therapeutic advance? Original Research
52 2010 POR PR Knappmann, AL Quality of over-the-counter medicines: a study with dipyrone brands commercialized in a drugstore in Cascavel city (Paraná, Brazil) Free Theme
53 2010 POR RJ Lago, RF Policy dilemmas in providing antiretroviral treatment in Brazil Free Theme
54 2010 POR PI Lima, GB The use of medicines storaged in the household in a population assisted by Family Health Program Free Theme
55 2010 POR SE Lyra, DPJ The influence of the advertising in the medication use in a group of elderly attended in a primary health care unit in Aracaju (Sergipe, Brasil) Free Theme
56 2010 POR RJ Nascimento, AC Drug advertising to the general public: conceptual parameters of a risk producer practice Original Research
57 2010 POR BA Oliveira, LCF Pharmaceutical Assistance in the Basic Units of Health: from the National Drug Policy to the Basic Attention to Health Free Theme
58 2010 POR SC Pereira, JR Situation of lawsuits concerning the access to medical products by the Health Department of Santa Catarina State, Brazil, during the years 2003 and 2004 Free Theme
59 2010 POR PB Portela, AS Medical prescriptions: adequate orientation to medicine use? Free Theme
60 2010 POR PA Sebastião, PCA The different point of view about the sanitary control of importation of psychotropic substances in Brazil Original Research
61 2010 POR RJ Silva, ACP Challenges to the national network of sanitary surveillance laboratories: the case of manipulated drugs Original Research
62 2010 POR RS Souza, MV High cost drugs for rare diseases in Brazil: the case of lysosomal storage disorders Review
63 2010 POR SC Trevisol, DJ Drug advertisement in a medicine school in the Southern of Brazil Free Theme
64 2010 POR DF Mota, DM Use abusive of benzydamine in Brazil: an overview in pharmacovigilan Original Research
65 2010 POR PE Aquino, DS Self-medication and health academic staff Free Theme
66 2010 POR RJ Pepe, VLE Health litigation and new challenges in the management of pharmaceutical services Original Research
67 2010 POR SC Galato, D Study of the use of medicine in elderly living in a city in the South of Santa Catarina (Brazil): a look at the polymedication Free Theme
68 2010 POR SE Lyra, DPJ Medication leaflets used by elderly with hypertension: adequacy of information for sanitary regulation and possible implications for health Original Research
69 2010 POR SP Carvalho, VAP Knowledge level for prescription of nonsteroidal anti-inflammatory by dentists in São José dos Campos, São Paulo State, Brazil Original Research
70 2010 POR DF Naves, JOS Self-medication: a qualitative approach of its motivations Original Research
71 2010 POR DF Leite, SN What right? Trajectories and perceptions of users in relation to the process of access to medication by legal writ in Santa Catarina State Original Research
72 2011 POR RS Rosa, C Representations and use intention of phytoterapy in primary health care Free Theme
73 2011 ENG RJ Esher, A Logic models from an evaluability assessment of pharmaceutical services for people living with HIV/AIDS Free Theme
74 2011 POR RS Frohlich, SE Are the drug prescription quality indicators of the World Health Organization still valid? Free Theme
75 2011 POR MG Saturnino, LTM Rural Internship in the professional training of pharmacists to serve in the Brazilian Unified Health System Free Theme
76 2011 POR RS Brum, LFS Prescribed and unprescribed drug use among pregnant patients attended by the Unified Health System in Santa Rosa (State of Rio Grande do Sul, Brazil) Thematic Supplement
77 2011 POR MG Gomes, PD Hormonal contraception: a comparison between patients of the private and public health network Thematic Supplement
78 2011 POR MG Melo, CM The use of apetite inhibitors by women: an insight based on the gender perspective Thematic Supplement
79 2011 POR RJ Paula, PAB The use of medication in the perception of users Hiperdia Program Free Theme
80 2011 SPN ESP Iñesta, A The pharmaceutical industry and the sustainability of healthcare systems in developed countries and in Latin America Thematic Supplement
81 2011 POR RJ Santos-Pinto, CDB The "Farmácia Popular do Brasil" Program and aspects of public provision of medicines in Brazil Free Theme
82 2011 POR DF Medeiros, EFF An interdisciplinary intervention as a strategy for Rational Use of Drugs by the elderly Thematic Supplement
83 2011 POR SC Oenning, D Patient awareness about drugs prescribed after medical appointment and prescription Free Theme
84 2011 POR RJ Rocha, DR Trangenics - Plant-Based Drugs (PBD) Free Theme
85 2011 POR BA Bastos, AA Facilitating factors and difficulties in the the implementation of sanitary surveillance of drugstores in Salvador, state of Bahia, Brazil Free Theme
86 2011 POR MG Daniela, A Dispensation of pharmaceuticals: proposal of a model for dispensation Free Theme
87 2011 POR PB Sá, LD Implementation of the DOTS strategy in the control of TB in Paraiba: between the political commitment and the involvement of the teams of the family health program (1999-2004) Free Theme
88 2011 POR BA Alencar, TOS Pharmaceutical Assistance in the Family Healthcare Program: points of affinity and discord in the organization process Free Theme
89 2011 POR RN Araújo, PTB Evaluation of quality medication prescription of a teaching hospital Free Theme
90 2011 POR RJ Santana, RAL National poison information system: the challenge of the data standardization Free Theme
91 2011 POR RS Costa, SM Knowledge of clients who suffer of pulmonary tuberculosis and their family members concerning the adherence of the treatment and associated factors in Rio Grande, Rio Grande do Sul State Free Theme
92 2011 POR RJ Osorio-de-Castro, CGS Uncomplicated malaria treatment in the Brazilian Amazon: knowledge, practices and perceptions of health workers in high-incidence municipalities. Free Theme
93 2011 POR PR Vosgerau, MZS Consumption of medicines by adults within an area covered by a family health unit Free Theme
94 2011 POR CE Silva, IM Self-medication in adolescence: a challenge to health education Free Theme
95 2012 POR DF Mota, DM Profile of mortality by intoxication with medication in Brazil, 1996-2005: portrait of a decade Thematic Supplement
96 2012 POR SC Blatt, CR General awareness and use of generic medication among citizens of Tubarão, state of Santa Catarina, Brazil Thematic Supplement
97 2012 POR MG Firmino, KF Use of benzodiazepines in local public health services in Coronel Fabriciano in the State of Minas Gerais Thematic Supplement
98 2012 POR RJ Esher, A Building Evaluation Criteria: experts and user satisfaction with pharmaceutical delivery services for HIV/Aids Thematic Supplement
99 2012 ENG/POR RS Rohden, F Accessed through sex: the medicalization of male sexuality at two different moments Thematic Supplement
100 2012 POR PR Bruning, MCR The use of phytotherapy and medicinal plants in primary healthcare units in the cities of Cascavel and Foz do Iguaçu - Paraná: the viewpoint of health professionals Opinion
101 2012 POR RS Junior, DS Court-ordered access to treatment of rare genetic diseases: Fabry Disease in the state of Rio Grande do Sul, Brazil Free Theme
102 2012 POR RS Guerin, GD Therapeutic itineraries of users of medication in a unit of the Family Heatlh Strategy Free Theme
103 2012 POR SC Galato, D Self-medication among university students: the influence of the field of study Free Theme
104 2012 POR MG Martins, ELM Prescriptions for anorectic psychotropic drugs in the municipality of Juiz de Fora, Minas Gerais, Brazil Free Theme
105 2012 POR RS Bianchin, MD Evaluation of the quality of propranolol and enalapril tablets supplied in the public health system in a southern Brazilian city Free Theme
106 2012 POR MG Luz, TCB Use of medication among hospital workers Free Theme
107 2012 POR SC Alano, GM Indicators of the pharmaceutical care service at the University of Southern Santa Catarina Free Theme
108 2012 SPN ARG Colautti, MA People living with HIV/AIDS and their link with the antiretrovirals provided by the National Programme in Argentina Thematic Supplement
109 2012 POR SC Dandolini, BW Rational use of antibiotics: an experiment for the health education of schoolchildren Free Theme
110 2012 POR RJ Corrêa, MCDV Abortion and misoprostol: health practices and scientific controversy Thematic Supplement
111 2012 POR DF Diniz, D Cytotec and abortion: the police, the vendors and women Thematic Supplement
112 2012 POR PI Carvalho, ALM Adherence to Drug Treatment among registered users in the "HIPERDIA" Program in Teresina in the State of Piauí Free Theme
113 2012 POR RJ Lima-Dellamora, EC Dispensing specialized component medicines in areas of the State of Rio de Janeiro Free Theme
114 2012 POR SC Alano, GM Awareness, consumption and access to emergency contraception among female university students in the south of the State of Santa Catarina Free Theme
115 2012 POR RJ Brito, MA Medicalization of Life: Ethics, Public Health and Pharmaceutical Industry Review
116 2013 POR SP Campos, RTO Autonomous Medication Management: an analytical intervention in mental health care services Thematic Supplement
117 2013 POR GO Braoios, A The use of antimicrobial drugs by the population in the city of Jataí, State of Goias, Brazil Free Theme
118 2013 ENG PR Guidoni, CM Analysis of treatment of comorbidities and the profile of medical consultations for diabetes mellitus Free Theme
119 2013 POR RJ Corrêa, AD An approach regarding the use of medication in biology textbooks as a strategy for health promotion Free Theme
120 2013 POR MG Sousa, CV Analysis of the decision to buy medicine in light of the existence of generic products: a study in the city of Belo Horizonte, Brazil Free Theme
121 2013 ENG RJ Paumgartten, FJR Clinical use and control on thalidomide dispensing in Brasilia-DF, Brazil, from 2001 to 2012 Free Theme
122 2013 POR RS Rocha BS Psychotropic drugs in the Family Health Strategy: profile of use, access and strategies to promote rational use Free Theme
123 2013 POR RJ Silva, MJS An evaluation of the services of state hospital pharmacies in Rio de Janeiro, Brazil Free Theme
124 2013 POR RS Moraes, CG Drug use among children between zero and six years old: a population baseline study in the south of Brazil Free Theme
125 2013 POR SP Ferreira, TR Analgesics, antipyretics and non-steroidal anti-inflammatory drugs in pediatric prescriptions Free Theme
126 2013 ENG MG Luz, TCB Social capital and under-utilization of medication for financial reasons among elderly women: evidence from two Brazilian health surveys Free Theme
127 2013 POR ESP and BRA Rubio, JS Cross-cultural adaptation to the European Portuguese of the questionnaire "Patient Knowledge about their Medications" (CPM-ES-ES) Free Theme
128 2013 POR SC Cruzeta, APS Factors associated with the understanding of medical prescriptions in the Unified Health System in a city in southern Brazil Free Theme
129 2013 POR RN Batista, AM Evaluation of medication advertising broadcast on radio stations Free Theme
130 2013 POR RJ Itaborahy, C Methylphenidate in Brazil: a decade of publications Free Theme
131 2013 POR RJ Nobre, PFS Off-label prescriptions in Brazil and in the US: legal aspects and paradoxes Free Theme
132 2013 POR SP Marchi, KC Adherence to medication among patients with Parkinson's disease treated at a specialized outpatient unit Free Theme
133 2013 POR RJ Falqueto, E Guidelines for an Expired Medication Collection Program in Brazil Free Theme
134 2013 POR DF Oliveira, MPF The socio-economic, epidemiological and pharmaco-therapeutic profile of institutionalized elderly individuals in Brasilia, Brazil Free Theme
135 2013 POR DF Medeiros, M The thesis of judicialization of health care by the elites: medication for mucopolysaccharidosis Free Theme
136 2013 POR SP Souza, ARL Contexts and patterns of undue use benzodiazepine among women Free Theme
137 2013 POR SP Takitane, J Amphetamine use by truck drivers on highways of Sao Paulo State: a risk for the occurrence of traffic accidents? Thematic Supplement
138 2013 POR PR Girotto, E Adherence to pharmacological and non pharmacological treatment for arterial hypertension and associated factors in primary care Free Theme
139 2013 POR RS Motter, FR Knowledge about pharmacotherapy among hypertensive patients Free Theme
140 2013 POR PI Fontenele, RP Phytotherapy in Primary Health Care: perspectives of managers and professionals in the Family Health Program of Teresina, Piauí, Brazil Free Theme
141 2013 SPN ARG Alonso, JP Palliative care: between humanization and medicalization at the end of life Free Theme
142 2014 POR BA Leão, DFL Evaluation of potential drug interactions in primary health care prescriptions in Vitória da Conquista, Bahia (Brazil) Free Theme
143 2014 ENG SP Francisco, PMSB The use of medication and associated factors among adults living in Campinas, São Paulo, Brazil: differences between men and women Free Theme
144 2014 POR RJ Lima, MAFD Contradictions of public health policies geared to rare disorders: the example of the Osteogenesis Imperfecta Treatment Program in the Brazilian Unified Health System (SUS). Opinion
145 2014 POR RJ Pádula, M Pharmaceutical care and suspended attention: compromise-formations between pharmacy and psychoanalysis Free Theme
146 2014 SPN ESP and BRA Rubio, JS Validation of the Portuguese version of an instrument to measure the degree of patient knowledge about their medication. Free Theme
147 2014 POR PR Takahama, CH Profile of exposure to medication among women of reproductive age attended in a Toxicologial Information Center. Free Theme
148 2014 POR RS Mota, DM Are there irrationalities in the consumption of anti-obesity drugsin Brazil? A pharmaco-econometric analysis of panel datasets Free Theme
149 2014 POR RJ Mendes, LVP Rational use of medicines by individuals with diabetes mellitus and arterial hypertension in the municipality of Rio de Janeiro, Brazil Free Theme
150 2014 POR SP Ribeiro, AG Antidepressants: use, adherence and awareness among medical students Free Theme
151 2014 POR PE Procopio, EVP Social representation of sexual violence and its relationship with the adherence to the chemoprophylaxis protocol of HIV in young women and adolescents Free Theme
152 2014 POR RJ Batista, AJS The challenges of nanotechnology for the sanitary vigilance of medication Free Theme
153 2014 POR BA Silva, TO Disposal of drugs: an analysis of the practices in the family health program Free Theme
154 2014 POR PA Cuentro, VS Drug prescriptions of patients treated in a geriatric outpatient ward of a university hospital: a descriptive cross-sectional study Original Research
155 2014 POR RJ Souza, PP Preparedness of pharmaceutical assistance for disasters: a study in five Brazilian municipalities Thematic Supplement
156 2014 POR RJ Magarinos-Torres, R Essential medicines and the selection process in management practices of pharmaceutical services in Brazilian states and municipalities Free Theme
157 2015 ENG/SPN/POR ESP/PORT Rubio, JS Measurement of patients’ knowledge of their medication in community pharmacies in Portugal Free Theme
158 2015 ENG/POR RJ Silva, RM “Farmácia Popular do Brasil” Program: characterization and evolution between 2004 and 2012 Original Research
159 2015 POR DF Soares, K Bioequivalence of dermatological topical medicines:the Brazilian scenario and the challenges for health surveillance Free Theme
160 2015 ENG MG Vicente, ART Uso de antidepressivos e fatores associados em idosos: o Projeto Bambuí Original Research
161 2015 POR RJ Costa, RDF The acquisition of medication to treat Alzheimer’s disease in Brazil: an analysis of federal purchases, 2008-2013 Original Research
162 2015 ENG/POR MG Botelho, SF Pharmacovigilance risk mitigation plans: action in public health to promote the safe use of medication Free Theme
163 2015 POR SP Zanella, CG The role of the pharmacist in dispensing medication in Adult Psychosocial Care Centers in the city of São Paulo, Capital of the State of São Paulo, Brazil Original Research
164 2015 ENG/POR SP Monteiro, CN Coverage by the public health services of medication and vaccines for the population with diabetes mellitus Free Theme
165 2015 ENG/POR SP Fonseca, E Federalism, the Economic-Industrial Health Care Complex and High-Cost Pharmaceutical Assistance in Brazil Free Theme
166 2015 ENG RS Trevisan, LM Acesso ao tratamento para fenilcetonúria por via judicial no Rio Grande do Sul, Brasil Free Theme
167 2015 ENG/POR GO Costa, SHN Prevalence of psychotropic drug use in military police units Free Theme
168 2015 ENG POR Pires, C Brand names of Portuguese medication: understanding the importance of their linguistic structure and regulatory issues Free Theme
169 2015 POR CE Silva, CDC Por uma filosofia do medicamento Free Theme
170 2016 POR RN Azevedo, AJP Consumption of anxiolytic benzodiazepines: a correlation between SNGPC data and sociodemographic indicators in Brazilian capitals Original Research
171 2016 POR DF Alexandre, RF Specialized Pharmaceutical Services Component: federative pact for ensuring the comprehensiveness of drug treatment in the Unified Health System (SUS) Letter
172 2016 POR SP Naloto, DCC Prescription of benzodiazepines for adults and older adults from a mental health clinic Free Theme
173 2016 POR SC Nakamura, CA Construction of the work process of the Family Health Support Nucleus: the experience of pharmacists in a city in the south of Brazil Free Theme
174 2016 ENG/POR RJ Silva, RM Pharmaceutical services in Rio de Janeiro Municipality, Brazil: development regarding selected aspects from 2008 to 2014 Original Research
175 2016 ENG/POR MG Pinto, IVL An evaluation of elderly people’s understanding of pharmacotherapy among those treated in the Primary Healthcare System in Belo Horizonte, Brazil Original Research
176 2016 ENG/POR SP Prado, MAMB Diabetes in the elderly: drug use and the risk of drug interaction Original Research
177 2016 ENG/POR MG Lopes, LM Use of potentially inappropriate medications by the elderly at home Original Research
178 2016 POR PR Petris, AJ Public sector participation in the supply of dyslipidemia medication in a population-based study Free Theme
179 2016 ENG/POR PR Girotto, E Continued use of drugs and working conditions among truck drivers Original Research
180 2016 POR RS Dresch, AP Patients’ knowledge regarding medication prescribed by dentists in southern Brazil Free Theme
181 2017 ENG/POR RJ Pimentel, A The brief life of Norplant® in Brazil: controversies and reassemblages between science, society and State Thematic Supplement
182 2017 ENG/POR SP Melo, DP Pharmacist's contribution to the promotion of access and rational use of essential medicines in SUS Free Theme
183 2017 ENG/POR RJ Bonan, C Absorption and metabolization of sex hormones and their transformation into contraceptive technologies: the paths taken by medical thought in Brazil Thematic Supplement
184 2017 ENG/POR MG Garcia, MM Economic evaluation of the Programs Rede Farmacia de Minas do SUS versus Farmacia Popular do Brasil Free Theme
185 2017 ENG/POR SP Melo, DO Training of pharmacy technicians for dispensing drugs in Primary Health Care Free Theme
186 2017 POR SP Yamauti, SM The essentiality and rationality of the Brazilian national listing of essential medicines Free Theme
187 2017 ENG/POR DF Araújo, SQ The organization of pharmaceutical services by 'health region' in Brazil's Unified Health System Thematic Supplement
188 2017 ENG/POR MG Martins, MAP Cross-cultural Adaptation of the Oral Anticoagulation Knowledge Test to the Brazilian Portuguese Free Theme
189 2017 ENG/POR SP Caccia-Bava, MCGG Availability of herbal medicines and medicinal plants in the primary health facilities of the state of São Paulo, Southeast Brazil: results from the National Program for Access and Quality Improvement in Primary Care Free Theme
190 2017 ENG/POR DF Santana, RS The regulation and adoption of health technologies under Brazil's Unified Health System: barriers to access to medicines for diseases of poverty? Original Research
191 2017 POR MG Silva, SN Pharmaceutical Assistance in Mental Health: a diagnosis of Psychosocial Care Centers Free Theme
192 2017 ENG/POR BA Lisboa, ES Why do people appeal to the courts for access to medication? The case of insulin analogues in Bahia (Brazil) Original Research
193 2017 ENG/POR/SPN RJ Luiza, VL Challenges in a product development partnership: a malaria treatment case study Thematic Supplement
194 2017 ENG/POR/SPN SP Fedatto, MS The AIDS Epidemic and the Mozambican Society of Medicines: an analysis of Brazilian cooperation Thematic Supplement
195 2017 ENG RN Costa, VS Prescription medication by physiotherapists: a Brazilian view of the United Kingdom, Canada, Australia and New Zealand Review
196 2017 ENG/POR/SPN SP Lima, JHS Global health and Brazilian foreign policy: the negotiations on innovation and intellectual property Thematic Supplement
197 2017 ENG/POR RJ Hasenclever, L The Brazilian phytotherapics industry: challenges and opportunities Original Research
198 2017 ENG/POR DF Pontes, MA Investment of financial resources for the procurement of medicines for primary care in Brazilian municipalities Original Research
199 2017 ENG/POR RJ Osorio-de-Castro, CGS Pharmaceutical Services: a field under consolidation Editorial
200 2017 ENG/POR SC Rover, MRM An evaluation of governance capacity of the specialized component of pharmaceutical services in Brazil Original Research
201 2017 ENG/POR MG Barbosa, MM Infrastructure evaluation of Pharmaceutical Services in the National Health System of Minas Gerais Original Research
202 2017 ENG/POR RJ Chaves, GC Public procurement of hepatitis C medicines in Brazil from 2005 to 2015 Original Research
203 2017 ENG RJ Bermudez, JZ Contemporary challenges on access to medicines: beyond the UNSG High-Level Panel Debate
204 2017 SPN/POR SP Costa, KS Coordination between pharmaceutical services for integrated pharmacotherapy: the case of Catalonia Original Research
205 2017 ENG/POR RJ Vidal TJ The lawsuits to antineoplastic drugs: the tip of an iceberg? Original Research
206 2017 ENG RJ Silva, RM Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines Original Research
207 2017 ENG/POR RS Guttier, MC Impact of interventions to promote the use of generic drugs: a systematic review Thematic Supplement
208 2017 ENG/POR RJ Caetano, R Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016 Original Research
209 2017 ENG RJ Paumgartten, FJR Nonbioequivalent prescription drug interchangeability, concerns on patient safety and drug market dynamics in Brazil Original Research
210 2017 ENG/POR RJ Mendoza-Ruiz, A Pan American Health Organization. Concepts, strategies and tools for a national pharmaceutical policy in the Americas. Washington, DC: PAHO, Medicines and Health Technologies Unit Review
211 2017 ENG MG Luz, TCB Pharmaceutical Services in Primary Health Care: are pharmacists and users on the same page? Original Research
212 2017 ENG/POR RJ Vasconcelos, DMM National Medicines Policy in retrospective: a review of (almost) 20 years of implementation Opinion
213 2017 ENG/POR AM Gomes, VP Prevalence of medicine use among Brazilian adults: a systematic review Review
214 2017 ENG USA Abbott, FM Reflections on the Report of the UN Secretary General’s High Level Panel on Access to Medicines Debate
215 2017 ENG RJ Azeredo, TB Sustainability of ARV provision in developing countries: challenging a framework based on program history Thematic Supplement
216 2017 ENG/POR RJ Esher, A Rational use of medicines, pharmaceuticalization and uses of methylphenidate Original Research
217 2017 POR SC Zeni, ALB Use of medicinal plants as home remedies in Primary Health Care in Blumenau - State of Santa Catarina, Brazil Free Theme
218 2017 ENG/POR SP Oliveira, JFM Medicine poisoning mortality trend by gender and age group, São Paulo State, Brazil, 1996-2012 Thematic Supplement
219 2018 ENG/POR MG Botelho, SF Analysis of new drugs registered in Brazil in view of the Unified Health System and the disease burden Free Theme
220 2018 ENG SP Okumura, LM A Glance in Hepatitis C Policy in Brazil: Access and Performance Letter
221 2018 POR ES Bonadiman, RL Satisfaction levels of users and verification of the knowledge of pharmacists in public pharmacies in the State of Espírito Santo, Brazil Free Theme
222 2018 ENG/POR PE Borba, AKOT Factors associated with elderly diabetic adherence to treatment in primary health care Free Theme
223 2018 ENG MG Vicente, ART Religiousness, social support and the use of antidepressants among the elderly: A population-based study Free Theme
224 2018 POR MG Silva, GD Profile of spending on the treatment of rheumatoid arthritis for patients of the Unified Health System in the state of Minas Gerais - 2008-2013 Free Theme
225 20118 POR RS Alves, SP The profile of caregivers to pediatric patients with cystic fibrosis Original Research
226 2018 ENG RS Tramontina, MY Comorbidities, potentially dangerous and low therapeutic index medications: factors linked to emergency visits Original Research
227 2018 POR CE Costa, AC Satisfaction of Chagas disease patients attended at a pharmaceutical care service in the State of Ceará, Brazil Thematic Supplement
228 2018 ENG/POR RJ Bermudez, JAZ Pharmaceutical Services and comprehensiveness 30 years after the advent of Brazil’s Unified Health System Thematic Supplement
229 2018 ENG/POR ITA Sachy, M Pharmaceutical Services in Mozambique: foreign aid in public provision of medicines Thematic Supplement
230 2018 ENG/POR RJ Freitas, PS Use of health services and medicines by hypertensive and diabetic patients in the municipality of Rio de Janeiro, Brazil Free Theme
231 2018 ENG/POR MG Silva, MRR Drug utilization and factors associated with polypharmacy in individuals with diabetes mellitus in Minas Gerais, Brazil Thematic Supplement
232 2018 ENG MA Lessa, CCR Prevalence and factors associated with surfactant use in Brazilian Neonatal Intensive Care Units: A multilevel analysis Free Theme
233 2018 POR RS Mota, DM Recommendation of ICD-10 codes for surveillance of adverse drug reactions and drug intoxication Free Theme
234 2018 POR SC Martinhago, F ADHD and Ritalin: neuronarratives in a virtual community of Facebook Social Network Thematic Supplement
235 2018 POR RS Mota, DM Analysis of the digital preference for age in the pharmacovigilance system in Brazil, 2008-2013 Free Theme
236 2018 POR RJ Madruga, LGSL Aspects related to the use of antiretrovirals in high complexity patients in the state of Rio de Janeiro Free Theme
237 2018 POR SC Mattos, G Medicinal plants and herbal medicines in Primary Health Care: the perception of the professionals Free Theme
238 2018 ENG/POR SP Nagai, KL Use of triggers tools to search for adverse drug reactions in the elderly admitted to emergency departments Free Theme
239 2018 ENG/POR SC Leite, SN Science, Technology and Pharmaceutical Policy on the agenda: contributions from the society to the 16th National Conference on Health Opinion
240 2019 ENG/POR MG Veloso, RCSG Factors associated with drug interactions in elderly hospitalized in high complexity hospital Original Research
241 2019 POR RS Raminelli, M Medications in breastfeeding: what evidence is there? Review
242 2019 ENG RJ Silva, MJS Origin-destination flows in chemotherapy for breast cancer in Brazil: implications for pharmaceutical services Free Theme
243 2019 POR SC Nascimento, DZ Alternatives for identifying drug interactions among adverse drug reactions in hospital units Letter
244 2019 POR GO Cardoso, BS The use of phytotherapy during pregnancy: a global overview Free Theme
245 2019 POR RJ Ribeiro, LHL Analysis of medicinal plant and herbal medicine programs in the Unified Health System (SUS) from the territorial perspective Original Research
246 2019 ENG ESP/BRA Iniesta-Navalón, C Potential and clinical relevant drug-drug interactions among elderly from nursing homes: a multicentre study in Murcia, Spain Free Theme
247 2019 ENG/POR RJ Lima, SGG Health technology assessment in Brazil - an international perspective Free Theme
248 2019 ENG PR Muller, EV Risk factors for cardiovascular disease in HIV/AIDS patients treated with highly active antiretroviral therapy (HAART) in the Central-southern region of the state of Paraná - Brazil Free Theme
249 2019 ENG/POR MG Carvalho, PP Factors associated with antiretroviral therapy adherence in adults: an integrative review of literature Original Research
250 2019 ENG/POR RJ Zorzanelli, RT Consumption of the benzodiazepine clonazepam (Rivotril®) in Rio de Janeiro State, Brazil, 2009-2013: an ecological study Free Theme
251 2019 ENG/POR PE Barbosa, VFB Medicalization and Indigenous Health: An analysis of the consumption of psychotropics by the Xukuru de Cimbres indigenous people Free Theme
252 2019 POR RJ Oliveira, NR Review of national and international legal and regulatory mechanisms on the management of drugs and the residues thereof Free Theme
253 2019 ENG/POR CE Santos, VF Use of the telephone for accessing people living with HIV/AIDS to antiretroviral therapy: systematic review Review
254 2019 POR SP Didone, TVN Validation of the “Conocimiento del Paciente sobre sus Medicamentos” (CPM-ES-ES) questionnaire Free Theme
255 2019 ENG SP Molino, CGRC Comparison of the methodological quality and transparency of Brazilian practice guidelines Free Theme
256 2019 ENG/POR SP Santimaria, MR Arterial hypertension diagnostic and drug therapy failure among Brazilian elderly - FIBRA Study Free Theme
257 2019 ENG/POR DF Barberato, LC The pharmacist in the Brazilian Primary Health Care: insertion under construction Review
258 2019 ENG RJ Paumgartten, FJR The tale of lenalidomide clinical superiority over thalidomide and regulatory and cost-effectiveness issues Free Theme
259 2019 POR RJ Santos, JS Potential drug interactions in adults and the elderly in primary health care Free Theme
260 2019 POR RJ Ferreira, DP Adherence of adolescents with cystic fibrosis to enzyme replacement therapy: associated factors Free Theme

Note: Language (ENG: English, POR: Portuguese, SPN: Spanish. Abbreviation according to the Brazilian ISBN Association).

Source: Authors, 2020.

Source: Authors, 2020.

Figure 1 Flow diagram of the selection of articles addressing themes in the field of Pharmaceutical Services (PS) published in the Journal Ciência & Saúde Coletiva between 1996 and 2019. C&SC, 2020. 

The time horizon covered by the review extended from the first volume of the Journal (published in 1996) to the last volume of 2019. In 1996, none of the articles published in the Journal met the eligibility criteria. The number of publications in the field of PS has grown considerably over the last 24 years, particularly from 2008, as shown in Figure 2.

Note: the left side of the graph shows the total number of articles published in C&SC, while the right side shows the number of articles on Pharmaceutical Services (PS).

Source: Authors, 2020.

Figure 2 Number of articles addressing themes in the field of pharmaceutical services published in the Journal Ciência & Saúde Coletiva between 1996 and 2019. C&SC, 2020. 

In April 2008, the Journal launched its first thematic issue on medicines, leading to an increase of 29 articles in comparison to the previous year. Since then, the annual number of publications has stood between 11 and 38.

Although the number of articles grew consistently, article characteristics varied considerably over the period (Figure 3).

Note: The lead author’s place of origin was classified by region in the case of Brazilian authors (South Region (S); Southeast Region (SE); Northeast Region (NE); North Region (N); Center-West Region (CW) or as outside Brazil (for non-Brazilian authors).

Source: Authors, 2020.

Figure 3 Characteristics of articles addressing themes in the field of pharmaceutical services published in the Journal Ciência & Saúde Coletiva between 1996 and 2019 - (A) article type, (B) language, (C) type of institution of origin of the lead author, and (D) lead author’s place of origin. C&SC, 2020. 

With regard to article type (A), most of the articles were open-topic, followed by original articles (which according to the Journal comprise empirical works). The latter were prominent mainly between 2004-2010 (37) and 2016-2019 (25). The total numbers of thematic articles do not coincide exactly with the publication of thematic issues on the field (2008 and 2017). The number of reviews was small and the number of articles in the other categories was relatively insignificant. The debate articles were published in the years in which the thematic issues were published.

The large majority of works were published in Portuguese (B). The number of articles written in English or both Portuguese and English was greater in the period 2016-2019. The type of institution of origin (C) that contributed most to the theme was public universities (141), across all years, followed by the Oswaldo Cruz Foundation (48) or Fiocruz (acronym in Portuguese). The annual number of articles produced by these types of institutions grew steadily throughout the period, while the number produced by private universities (35) and foreign institutions (10) fell. Brazil’s National Health Surveillance Agency, ANVISA, published articles in the periods 2004-2010 (6) and 2011-2015 (1).

The majority of the lead authors were from the Southeast Region, followed by the South, Northeast, Center-West, North regions, and outside Brazil. The annual number of articles from authors from the Southeast Region grew throughout the period, while the number produced by authors from the other regions remained stable. Authors from the North Region and outside Brazil made only a modest contribution to the theme over the study period, showing a decrease in publications in the last period (2016-2019), and promoting an increase in publications by these authors remains a challenge.

An initial analysis of the themes addressed by the articles was conducted based on the key words. The 260 selected articles contained 909 key words. Duplicate words were eliminated, resulting in 550 words, 406 of which (74%) appeared only once. The 10 most frequent key words were descriptors: assistência farmacêutica or pharmaceutical services (38), medicamento or medication (a synonym of the descriptor ‘preparações farmacêuticas’ or pharmaceutical preparations) (35), uso de medicamentos or medicine use (23), sistema único de saúde or unified health system (20), atenção primária em saúde or primary health care (18), farmacoepidemiologia or pharmacoepidemiology (17), vigilância sanitária or health surveillance (13), and idoso or the elderly (12).

Figure 4 shows the trends in the primary themes based on the conceptual framework for PS in Brazil described in the literature7-9.

Source: Authors, 2020.

Figure 4 Proportion of articles published in the Journal Ciência & Saúde Coletiva between 1996 and 2019 in the field of pharmaceutical services, by primary theme. C&SC, 2020. 

Figure 5 shows the percentage distribution of the primary themes in the four time-blocks covered by this study. Medicine utilization was consistently the most frequent core theme throughout the period, with 161 articles, followed by management, with 56 articles, and tangential aspects of the PM cycle, addressed by 43 articles.

Source: Authors, 2020.

Figure 5A and B Secondary themes addressed by the articles published in the Journal Ciência & Saúde Coletiva between 1996 and 2019 in the field of pharmaceutical services, by primary theme - (A) Management, (B) Tangential aspects of the PS Cycle, and (C) Medicine Utilization. C&SC, 2020. 

Source: Authors, 2020.

Figure 5C Secondary themes addressed by the articles published in the Journal Ciência & Saúde Coletiva between 1996 and 2019 in the field of pharmaceutical services, by primary theme - (A) Management, (B) Tangential aspects of the PS Cycle, and (C) Medicine Utilization. C&SC, 2020. 

The range of secondary themes increased steadily over the period, as demonstrated by Figure 5 , which shows the secondary themes under each primary theme.

Figure 5 shows that the scope of the publications became increasingly complex over the study period, with the introduction of multiple secondary themes. The primary theme that showed the widest range of secondary themes was medicine utilization (A), starting with a relatively lower number in the period 1996-2003, but increasing thereafter.

In the primary theme management (B), articles initially concentrated mainly on the secondary theme medicines policy, with the emergence of several new themes thereafter, such as public provision, public procurement, technology assessment, and PS services. The core theme tangential aspects of the PM cycle (C) encompassed secondary themes related to health regulation across all periods, with the themes global health, registration, technology assessment, and research and development emerging in the last period.

With the classification of the articles into primary themes, secondary themes, and specific topics, it was possible to build the ontology of PS in the pages of the C&SC set out in Chart 2.

Chart 2 Ontology of pharmaceutical services in the Journal Ciência & Saúde Coletiva, between 1996 and 2019. C&SC 2020. 

Primary Theme Secondary Theme Specific Topics
Tangential Aspects of the PS Cycle (43) Health Technology Assessment (2) Incorporation of Medicines (2)
Medicine Waste Management (1) Frameworks and Concepts (1)
Pharmacy Industry (4) Herbal Medicines (2); Generics (1) Biotechnology (1)
Research and Development (1) Antimalarial Medicine (1)
Medicine Policy (7) Antiretroviral Medicines (2); Generics (1); Frameworks and Concepts (2); Global Health (2)
Pharmaceutical Advertising (1) Frameworks and Concepts (1)
Intellectual Property (1) Antiretroviral Medicines (1)
Registration (1) Incorporation of Medicines (1)
Health Regulation (23) Commercialization of Medicines (1); Medicine Quality Control (1); Pharmacovigilance (1); Generics (1); Medicine Waste Management (2); Medicine Information (2); Frameworks and Concepts (2); Manipulated Medicines (2); Nanotechnology(1); Psychotropic Drugs (1); Pharmaceutical Advertising (5); Registration (2); Medicine Labeling (1); Pharmaceutical Services (1)
Global health/International cooperation (2) Antiretroviral Medicines (1); Intellectual Property (1)
Management (56) Access (3) Hypertension and/or Diabetes (2); Popular Pharmacy Program (1)
Acquisition (2) Public Procurement (2)
Primary Health Care (3) Pharmaceutical Services Assessment (1); Frameworks and Concepts (2)
Pharmaceutical Services Assessment (7) Pharmaceutical Care (1); Specialized Components of Pharmaceutical Services (2); Hospital Pharmacy (1); Frameworks and Concepts (1); Pharmaceutical Services (2)
Health Technology Assessment (2) Frameworks and Concepts (1); Clinical Practice and Therapy Guides (1)
Public Procurement (1) Hepatitis C (1)
Medicine Shortages (1) Access (1)
Disasters and Emergencies (1) Preparation
Pharmacoeconomics (3) Frameworks and Concepts (2); Popular Pharmacy Program (1)
Medicine Waste Management (2) Primary Health Care (1); Frameworks and Concepts (1)
Judicialization of Medicines (8) Antineoplastic Agents (1); Right to Health (1); Rare Diseases (3); Insulin (1); Therapeutic Itinerary (1); Medicine Provision (1)
Role of the Pharmacy Professional (1) Pharmacy Education (1)
Medicine Policy (12) Antimicrobial Medicines (1); Specialized Components of Pharmaceutical Services (2); Rare Diseases (1); Herbal Medicines (1); Hepatitis C (1); Frameworks and Concepts (4); Popular Pharmacy Program (1); Pharmaceutical Services (1)
Popular Pharmacy Program (1) Antihypertensive Medicines (1)
Public Provision (2) Dyslipidemia (1); Strategic Medicines (1)
User Satisfaction (1) Medicine Dispensing (1)
Medicine Selection (2) Essential Medicines (2)
Pharmaceutical Services (4) Primary Health Care (1); Antineoplastic Agents (1); Mental Health (1), Regionalization (1)
Medicine Utilization (161) Access (2) Generics (1); Herbal Medicines (1)
Medication Adherence (14) Antiparkinson Drugs (1); Antiretroviral Medicines (4); Rare Diseases (1); Hypertension and/or Diabetes (2); The elderly (3); Frameworks and Concepts (2); Sexual Violence (1)
Pharmaceutical Care (5) Frameworks and Concepts (2); Pharmaceutical Services (1); The elderly (1); User Satisfaction (1)
Primary Health Care (5) Herbal Medicines (3); Therapeutic Itinerary (1); Hypertension and/or Diabetes (1)
Self-medication (4) Analgesics (1); The elderly (1); Students (1); Commercialization of Medicines (1)
Knowledge about Medicines (26) Cross-cultural Adaption(4); Adherence (1); Anti-inflammatory Drugs(1); Antimalarial Medicine (1); Antimicrobial Medicines (1); Antiretroviral Medicines (1); Storage (1); Primary Health Care (3); Contraceptives (1); Rare Diseases (1); Herbal Medicines(1); Generics (1); Hypertension and/or Diabetes (2); The elderly(2); Pediatrics/Neonatology(1); Prescription (1); Health Promotion(1); Psychotropic Drugs (2)
Consumption of Medicines (16) Adults (2); Primary Health Care (1); Self-medication (1); Generics (1); The elderly (3); Pediatrics/Neonatology (2); Pharmaceutical Advertising (1); Psychotropic Drugs (5)
Medicine Dispensing (3) Frameworks and Concepts (2); Primary Health Care (1)
Pharmacoeconomics (2) Anorectics (1); Rheumatoid Arthritis (1)
Pharmacoepidemiology (26) Anorectics (1); Antimicrobial Medicines (2); Antiretroviral Medicines (1); Primary Health Care (2); Contraceptives (2); Gender (1); Pregnant Women (2); Hypertension and/or Diabetes (2); The elderly(3); Medication Poisoning (1); Psychotropic Drugs (3); Thalidomide (1); Frameworks and Concepts (2); Pediatrics/Neonatology(2); Health Workers (1)
Pharmacovigilance (4) Psychotropic Drugs (1); Medication Interactions (1); Medication Poisoning (1); The elderly (1)
Herbal Medicines (1) Pregnant Women (1)
Medicine Information (1) Methylphenidate (1)
Medication Interactions (5) The elderly (4); Pharmacovigilance (1)
Medication Poisoning (1) Gender (1)
Medicalization and Pharmaceuticalization (18) Adolescents (1); Anorectics (2); Antiretroviral Medicines (1); Self-medication (1); Contraceptives (1); Palliative Care (1); Gender (1); Frameworks and Concepts (4); Methylphenidate(1); Misoprostol (1); Psychotropic Drugs (3); Social Representation of Medicines(1)
Role of the health professional (1) Frameworks and Concepts (1)
Role of the Pharmacy Professional (10) Primary Health Care (4); Frameworks and Concepts (4); Mental Health (1); User Satisfaction (1)
Medicine Policy (1) Rare Diseases (1)
Medicine Prescribing (10) Antimicrobial Medicines (2); Pharmaceutical Services Assessment (1); Hospital Pharmacy (1); Knowledge about Medicines (1); Herbal Medicines(1); The elderly(1); Frameworks and Concepts (1); Psychotropic Drugs (1); Health Regulation (1)
Pharmaceutical Advertising (1) Medicine Prescribing (1)
Psychotropic Drugs (1) Medicine Policy (1)
Health Regulation (1) Misoprostol (1)
Information Systems (3) Pharmacovigilance (2); Medication Poisoning (1)

Source: Authors, 2020.

The chart shows each primary theme together with the dependent secondary themes and specific topics and the frequency of each classification. Two characteristics in particular stand out in the box: first, the same secondary themes and specific topics are present across the different primary themes, depending on the approach of the study; second, secondary themes also appear as specific topics in cases where they are the object of study. With regard to specific topics, the findings show that the frequency of the generic topic ‘frameworks and concepts’ decreased over the period, while the frequency of ‘the elderly’, ‘psychotropic drugs’, and ‘primary health care’ increased, becoming prominent topics in the publications. The relatively large number of articles with the secondary theme knowledge about medicines (26 articles), pharmacoepidemiology (26), and medicalization and pharmaceuticalization (18), also warrants highlighting.

The primary themes showed the following number of secondary themes and specific topics, respectively: tangential aspects of the PM cycle, 10 and 21; management, 18 and 31; and medicine utilization, 24 and 50. The box also shows the interconnection between each primary theme and the secondary themes and specific topics, according to the number of related articles.


The growth of the theme of PS in the pages of the C&SC in recent years is notable. The publication of a thematic issue on medicines in 2008 marked an inflection point for the theme, appearing to have aroused interest in the area among researchers.

A number of journals in the area of Pharmaceutical Sciences reflect biomedical research output - be it laboratory studies, research in the field of pharmacology, or clinical studies. The research output is accompanied by the fact that most post-graduate courses in pharmaceutical sciences are within the pharmacy framework rather than the public health frameworkk22,23.

However, the findings show a growth in studies describing the results of pharmaceutical services within the theme of drug utilization research (DUR), which reflects the discussions and changes in the field over recent years. The increase in the number of works is to be expected, mainly due to the publication of national curriculum guidelines for pharmacy degrees in 2002 and 2017. These guidelines reinforce that essential content for the training of pharmacy professionals should encompass the health-disease process, focusing on users, their family, and the community, and drawing on the human and social sciences24-26.

PS has gained more prominence in the published literature over the years, covering a range of topics, including the development of the SUS11,27, health issues and health spending28,29, the evolution of pharmacoepidemiology30,31, and the discussion of activities and procedures designed to meet the population’s health needs32,33. Despite the increasing presence of articles about PS in other national periodicals, journals in the field of public health like the C&SC remain focused more on the so-called “social” aspects of the pharmaceutical sciences. It is evident that the C&SC is an important vehicle for disseminating the theme, accounting for between 5 and 10% of the annual publication of articles on PS in Brazil over the last 11 years.

Internationally, there are a number of periodicals in the fields of pharmaceutical sciences and public health. As in Brazil, scientific output on the theme tends to be dichotomized between biomedical research and the social sciences. However, conceptual differences related to the term PS adopted in the descriptors used in and outside Brazil remain a challenge for the appropriation of the theme across countries and influences publications in the field of PS. Assistência Farmacêutica has been translated to English in a variety of ways. A first such translation was “pharmaceutical care”. However, the international literature emphasizes the element of care, which involves interaction between the pharmacy professional and the patient, contributing to improve quality of life34. The term pharmaceutical care therefore refers to Atenção Farmacêutica in Portuguese. On the other hand, a free translation of this assistência farmacêutica would be “pharmaceutical assistance”, which is completely inadequate as a descriptor, because it refers to pharmaceutical benefits.

The term pharmaceutical services35 emerged in the context of the Americas as part of the discussions about local health systems. Although this term has not achieved unanimity, because it can refer to specific point-of-care services36-38, it is important to highlight that the Latin American and Caribbean Center on Health Sciences Information, or BIREME, adopts the English and Spanish terms pharmaceutical services and “servicios farmacéuticos” for assistência farmacêutica39. Thus, although the terms are close, but not identical, a concerted effort should be made to align terms towards a common, official synonym. Ensuring the use of the same descriptors is a strategy that seeks to consolidate the field and promote commonality throughout scientific publications. In the pages of the C&SC, this effort seems to be working, with poor translations of the term PS being witnessed only on rare occasions, especially after 2010.

Open-topic articles, and more recently original articles, make up a significant proportion of published articles, reflecting the adoption of this practice in health facilities and management practices. There are still relatively few reviews in the field of PS, be they systematic, narrative, scoping, or qualitative. This may be because the growth in research in this area is only recent and there is therefore an unmet need to bring together enough references on the same topic to ensure a robust review40-44.

An increasing number of articles are submitted for publication in English. The strategy adopted by the C&SC and other journals to translate articles and accept papers written in English and Spanish, based on a requirement established by SciELO, has helped not only to disseminate knowledge but also place authors in a better position for dialogue with international peers and partners. The topics brought by the articles on PS, such as pharmacoepidemiology, resource allocation, and technology assessment, are increasingly finding shared identity outside Brazil. In addition, the study of the advances made by the SUS - right to health and universal access to health care - reinforces the importance of studying system disparities brought about by context and disruption phenomena, which generate inequalities - leading for example to health-related litigation to gain access to medicines - and draw interest from the international community45-48.

The lead authors were predominantly from academic institutions such as universities and FIOCRUZ, showing that the theme is being disseminated and producing knowledge. However, it is public universities that dominate PS research output. Foreign institutions and authors made only a small contribution to publications over the period.

The findings show that output remains concentrated in the Southeast, the country’s leading region for scientific output. This reflects so many other “concentrations” in the Southeast, including research groups, research funding, and decision-making power in the allocation resources to health and PS49.

The predominant primary theme across all periods was medicine utilization. Medicine utilization involves questions often related to the characteristics of medicines, professionals - prescribers, dispensers - and patients. Its development is therefore largely driven by the need to understand the positive and negative consequences of medicine utilization, its relationship with health regulations, and the real obligation to provide inputs to support the adequate management of these supplies.

The first period (1996-2003) coincides with the beginnings of PS in the recently created SUS and the publication of the NMP. It is no coincidence therefore that open-topic articles addressing theoretical frameworks and concepts were the most frequent. The history of the normative framework that delineates PS in Brazil is recent. Despite the introduction of the NMP in 1998, the infra-legal rules that govern PS only emerged later. The drug fraud crisis of 1998 led to a focus on health surveillance and medicine regulation. The system, faced with the challenge of restructuring itself, focused on quality assurance for supplies and products, forcing the reshaping of public and private pharmaceutical services to ensure the guarantee of origin of products provided to the public50. This led to the emergence of themes related to regulation in the pages of the C&SC.

Another important moment was the launch of the Pacto pela Saúde or “Health Pact” in 200651,52. The Pact introduced a package of institutional reforms for the SUS, with a series of innovations in management processes and instruments, including the funding of PS. This gave rise to the appropriation of the new rules and their “impacts” on the population and system by both managers and academics.

In the second period (2004-2010), the country witnessed the expansion of the SUS and establishment of PS programs and original articles became more prominent. In this regard, studies addressing topics related to the components of PS funding, medicine access programs like the Farmácia Popular, and judicialization only began to be published after the limits and possibilities of PS and the SUS were delineated. Although medicine utilization remained the dominant theme throughout, management gained in relative importance over the period, reflecting professional practice in the organization of the SUS53-57. During the third period (2011-2015), PS experienced the turbulence generated by the conceptual modification of RENAME, the country’s essential medicines list, reducing it from a set of low, medium, and high complexity medicines to meet health needs to a mishmash of funding lists of on-demand medicines55.

With regard to the primary theme tangential aspects of the PM cycle, the number of publications addressing themes that shaped the field of PS at the beginning, such as health regulation, intellectual property, and the struggle for access to antiretroviral medicines, decreased proportionately over the period with the emergence of new themes like global health and international cooperation58,59. It is interesting to note that the number of studies addressing this primary theme increased in the last period (2016-2019), suggesting that it is the more innovative and global themes in the field of PS that will be more discussed and explored in coming years.

The ontology60 produced by this study reveals the wide diversity of themes related to the field of PS in the pages of the C&SC, bringing together a variety of recurring secondary themes, together with new topics (such as global health and international cooperation), others that have taken on greater prominence (such as pharmacoepidemiology, pharmacoeconomics, health technology assessment, and pharmaceuticalization and medicalization), and emerging themes like health emergencies and disasters. Our findings show that there are numerous specific topics that cut across the primary and secondary themes. It is this variety and range of perspectives that promotes the dissemination of various points of view on the same topic, bringing development and conceptual solidity and pointing to new pathways for analysis and new knowledge. The ontology shows that the field is not static, but rather dynamic, and, more importantly, integrated, demonstrating its utility for the investigation of relations of interdependency between themes and for future articles on the theme of PS.

This study has some limitations. Although article identification was conducted by the entire review team and special care was taken to ensure a systematic selection process and clear up doubts regarding article eligibility, there were differences of opinion regarding the inclusion of articles. However, the joint review of the articles by the review team meant that it was possible to resolve these differences. Another challenge was the classification of articles according to primary themes, secondary themes, and specific topics. Differing views on the themes and their interdependencies meant that the classification relied on objective judgment, which may have resulted in reductionist decisions regarding themes. Nevertheless, we believe that the ontology depicts the diversity of the field.

Finally, the descriptors used for an initial search of the SciELO website did not provide a reliable search, resulting is a series of information gaps. The search was only successful when it was repeated and validated by checking C&SC’s site. This shows the utility and reliability of C&SC’s site as a tool for future reviews using the Journal.


Our findings reveal the sustained growth and dynamism of the field of PS in the pages of the C&SC over the last 24 years, becoming one of the Journal’s core themes today. Although the Journal includes studies from all regions of Brazil, efforts should be made to increase the contribution of authors from the North, Northwest, and Center-West regions and authors outside Brazil. The types of institutions that contributed most to the expansion of the field were public universities, followed by Fiocruz.

The articles were classified into core primary themes (medicine utilization, management, and tangential aspects of the PM cycle), complemented by secondary themes and specific topics, illustrating the diversity of and interrelation between themes.

Different phenomena that had an impact on public health over the study period were present to a greater or lesser extent. As we have seen, PS has reflected the emerging knowledge in the field of medicines and medication therapy. It was PS that brought the theme of judicialization to the fore; It was PS that brought the discussion of themes like access to medicines and intellectual property. New and challenging studies on the theme directed at the C&SC are awaited.

PS is an expanding field that encompasses the complexity of public policy combined with management and frontline activities involved in the delivery of health care to the population. The field produces a diverse range of interrelations and it is hoped that these interrelations will be increasingly addressed by future publications.


1 Kostriba MSJ, Alwarafi A, Vlceka J. Social Pharmacy as a Field of Study in Undergraduate Pharmacy Education. Indian J Pharm Educ Res 2014; 48(1):6-12. [ Links ]

2 Sorensen EW, Mount JK, Christensen ST. The concept of social pharmacy. The Chronic Ill 2003; 7:8-11. [ Links ]

3 Brasil. Lei no 8.080, de 19 de setembro de 1990. Dispõe sobre as condições de promoção, proteção e recuperação da saúde, a organização e o funcionamento dos serviços correspondentes e dá outras providencias. Diário Oficial da União 1990; 19 set. [ Links ]

4 Brasil. Portaria no 3.916, 30 de outubro de 1998. Aprova a Política Nacional de Medicamentos. Diário Oficial da União 1998; 10 nov. [ Links ]

5 Brasil. Portaria no 176, de 8 de março de 1999. Estabelece critérios e qualificação dos municípios e estados ao Incentivo à Assistência Farmacêutica Básica e define valores a serem transferidos. Diário Oficial da União 1999; 11 mar. [ Links ]

6 Brasil. Resolução no 338, de 06 de maio de 2004. Aprova a Política Nacional de Assistência Farmacêutica. Diário Oficial da União 2004; 20 maio. [ Links ]

7 Quick JD, Hogerzeil HV, Rankin JR, Dukes MNG, Laing R, Garnett A, O'Connor RW, editores. Managing drug supply: the selection, procurement, distribution, and use of pharmaceuticals. Connecticut: Kumarian Press; 1997. [ Links ]

8 Osorio-de-Castro CGS, Luiza VL, Castilho SR, Oliveira MA, Jaramillo NM, organizadores. Assistência farmacêutica: gestão e prática para profissionais da saúde. Rio de Janeiro: Editora Fiocruz; 2014. [ Links ]

9 Marin N, Luiza VL, Osorio-de-Castro CGS, Machado-dos-Santos S, organizadores. Assistência farmacêutica para gerentes municipais. Brasília: OPAS/OMS; 2003. [ Links ]

10 Osmo A, Schraiber LB. O campo da Saúde Coletiva no Brasil: definições e debates em sua constituição. Saúde Soc 2015; 24(Supl. 1):205-218. [ Links ]

11 Bermudez JAZ, Esher A, Osorio-de-Castro CGS, Vasconcelos DMM, Chaves GC, Oliveira MA, Silva RM, Luiza VL. Assistência Farmacêutica nos 30 anos do SUS na perspectiva da integralidade. Cien Saude Colet 2018; 23(6):1937-1949. [ Links ]

12 Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J 2009; 26(2):91-108. [ Links ]

13 Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc 2015; 13(3):141-146. [ Links ]

14 Brasil. Decreto no 7.508, de 28 de junho de 2011. Regulamenta a Lei no 8.080, de 19 de setembro de 1990, para dispor sobre a organização do Sistema Único de Saúde - SUS, o planejamento da saúde, a assistência à saúde e a articulação interfederativa, e dá outras providencias. Diário Oficial da União 2011; 29 jun. [ Links ]

15 Conselho Nacional dos Secretários de Saúde (CONASS). A Lei no 141/2012 e os Fundos de Saúde. Brasília: CONASS; 2013. [ Links ]

16 Brasil. Portaria no 1.554, de 30 de julho de 2013. Dispõe sobre as regras de financiamento e execução do Componente Especializado da Assistência Farmacêutica no âmbito do Sistema Único de Saúde (SUS). Diário Oficial da União 2013; 31 jul. [ Links ]

17 Brasil. Portaria no 1.555, de 30 de julho de 2013. Dispõe sobre as regras de financiamento e execução do Componente Básico da Assistência Farmacêutica no âmbito do Sistema Único de Saúde (SUS). Diário Oficial da União 2013; 31 jul. [ Links ]

18 Brasil. Portaria no 2.084, de 26 de outubro de 2005. Estabelece normas, responsabilidades e recursos a serem aplicados no financiamento da Assistência Farmacêutica na Atenção Básica e define o elenco mínimo obrigatório de medicamentos. Diário Oficial da União 2005; 10 nov. [ Links ]

19 Brasil. Portaria no 3.193, de 9 de dezembro de 2019. Altera a Portaria de Consolidação no 6/GM/MS, de 28 de setembro de 2017, para dispor sobre o financiamento do Componente Básico da Assistência Farmacêutica no âmbito do Sistema Único de Saúde (SUS). Diário Oficial da União 2019; 10 dez. [ Links ]

20 Vieira FS. Implicações de decisões e discussões recentes para o financiamento do Sistema Único de Saúde. Saúde Debate 2016; 40(109):187-199. [ Links ]

21 Oliveira MA, Bermudez JAZ, Osorio-de-Castro CGS. Assistência farmacêutica e acesso a medicamentos. Rio de Janeiro: Editora Fiocruz; 2007. [ Links ]

22 Almeida RB, Mendes DHC, Dalpizzol PA. Ensino farmacêutico no Brasil na perspectiva de uma formação clínica. Rev Cien Farm Básica Apl 2014; 35(3):347-354. [ Links ]

23 Angonesi D, Sevalho G. Atenção Farmacêutica: fundamentação conceitual e crítica para um modelo brasileiro. Cien Saude Colet 2010; 15(Supl. 3):3603-3614. [ Links ]

24 Brasil. Resolução CNE/CES no 2, de 19 de fevereiro de 2002. Institui Diretrizes Curriculares Nacionais do Curso de Graduação em Farmácia. Diário Oficial da União 2002; 4 mar. [ Links ]

25 Brasil. Resolução CNE/CES no 6, de 19 de outubro de 2017. Institui Diretrizes Curriculares Nacionais do Curso de Graduação em Farmácia. Diário Oficial da União 2017; 20 out. [ Links ]

26 Conselho Federal de Farmácia (CFF). Serviços farmacêuticos diretamente destinados ao paciente, à família e à comunidade: contextualização e arcabouço conceitual. Brasília: CFF; 2016. [ Links ]

27 Gadelha CAG, Temporão JG. Desenvolvimento, Inovação e Saúde: a perspectiva teórica e política do Complexo Econômico-Industrial da Saúde. Cien Saude Colet 2018; 23(6):1891-1902. [ Links ]

28 Caetano R, Hauegen RC, Osorio-de-Castro CGS. A incorporação do nusinersena no Sistema Único de Saúde: uma reflexão crítica sobre a institucionalização da avaliação de tecnologias em saúde no Brasil. Cad Saúde Pública 2019; 35(8):e00099619. [ Links ]

29 Moraes EL, Osorio-de-Castro CGS, Caetano R. Compras federais de antineoplásicos no Brasil: análise do mesilato de imatinibe, trastuzumabe e L-asparaginase, 2004-2013. Physis 2016; 26(4):1357-1382. [ Links ]

30 Bégaud B. A history of pharmacoepidemiology. Therapie 2019; 74(2):175-179. [ Links ]

31 Sommet A, Pariente A. Methods in pharmacoepidemiology. Therapie 2019; 74(2):187-197. [ Links ]

32 Magarinos-Torres R, Pepe VLE, Osorio-de-Castro CGS. Estruturação da assistência farmacêutica: plano de ação para a seleção de medicamentos essenciais. Cad Saude Colet 2013; 21(2):188-196. [ Links ]

33 Steiner L, Maraj D, Woods H, Jarvis J, Yaphe H, Adekoya I, Bali A, Persaud N. A comparison of national essential medicines lists in the Americas. Rev Panam Salud Publica 2020; 44:e5. [ Links ]

34 Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47(3):533-543. [ Links ]

35 Pan American Health Organization (PAHO). Guidelines for the Development of Pharmaceutical Services in Primary Health Care. Washington: PAHO/WHO; 2011. [ Links ]

36 Bradley F, Elvey R, Ashcroft DM, Hassell K, Kendall J, Sibbald B, Noyce P. The challenge of integrating community pharmacists into the primary health care team: A case study of local pharmaceutical services (LPS) pilots and interprofessional collaboration. J Interprof Care 2008; 22(4):387-398. [ Links ]

37 Sczupak CA, Conrad WF. Relationship between patient-oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus. Am J Hosp Pharm 1977; 34(11):1238-1242. [ Links ]

38 Singhal PK, Raisch DW, Gupchup GV. The Impact of Pharmaceutical Services in Community and Ambulatory Care Settings: Evidence and Recommendations for Future Research. Ann Pharmacother 1999; 33(12):1336-1255. [ Links ]

39 Descritores em Ciências da Saúde (DeCS) [Internet]. Versão 2020. São Paulo: BIREME/OPAS/OMS; 2020. [ Links ]

40 Becker MW, Lunardelli MJM, Tovo CV, Blatt CR. Drug and herb-induced liver injury: A critical review of Brazilian cases with proposals for the improvement of causality assessment using RUCAM. Ann Hepatol 2019; 18(5):742-750. [ Links ]

41 Domingues I. O sistema de comunicação da ciência e o taylorismo acadêmico: questionamentos e alternativas. Estud Av 2014; 28(82):225-250. [ Links ]

42 Gomes VP, Silva MT, Galvão TF. Prevalência do consumo de medicamentos em adultos brasileiros: uma revisão sistemática. Cien Saude Colet 2017; 22(8):2615-2626. [ Links ]

43 Kentab BY, Barry HE, Al-Aqeel SA, Hughes CM. A systematic review of pharmacists' interventions to support medicines optimisation in patients with visual impairment. Int J Clin Phar 2019; 41(6):1400-1407. [ Links ]

44 Wright DJ, Maskrey V, Blyth A, Norris N, Alldred DP, Bond CM, Desborough J, Hughes CM, Holland RC. Systematic review and narrative synthesis of pharmacist provided medicines optimization services in care homes for older people to inform the development of a generic training or accreditation process. Intl J Pharm Pract 2020; 28(3):207-219. [ Links ]

45 Chagas VO, Provin MP, Mota PAP, Guimarães RA, Amaral RG. Institutional strategies as a mechanism to rationalize the negative effects of the judicialization of access to medicine in Brazil. BMC Health Serv Res 2020; 20(1):80. [ Links ]

46 Paula EA, Silva RAM, Siqueira PSF, Melo DO. Registro de medicamentos com indicação agnóstica já é realidade no Brasil, o que significa para a judicialização? Cad Ibero Am Direito Sanit 2019; 8(4):145-155. [ Links ]

47 Pedro EM, Caetano R, Teodoro CRS, Steffen RE, Silva RM. Incorporação de medicamentos sem registro sanitário no SUS: um estudo das recomendações da Comissão Nacional de Incorporação de Tecnologias no período 2012-2016. Vigil Sanit Debate 2018; 6(3):12-21. [ Links ]

48 Rutter PM, Harrison T. Differential diagnosis in pharmacy practice: Time to adopt clinical reasoning and decision making. Res Social Adm Pharm 2020; 16(10):1483-1486. [ Links ]

49 Silva RM, Caetano R. Um exame dos fluxos financeiros do Ministério da Saúde em pesquisa e desenvolvimento (2003-2005), segundo a Agenda Nacional de Prioridades de Pesquisa em Saúde. Cad Saúde Pública 2011; 27(4):687-700. [ Links ]

50 Brasil. Portaria no 802, de 8 de outubro de 1998. Institui o Sistema de Controle e Fiscalização em toda a cadeia dos produtos farmacêuticos. Diário Oficial da União 1998; 9 out. [ Links ]

51 Brasil. Portaria no 399, de 22 de fevereiro de 2006. Divulga o Pacto pela Saúde 2006 - Consolidação do SUS e aprova as Diretrizes Operacionais do referido Pacto. Diário Oficial da União 2006; 23 fev. [ Links ]

52 Vasconcelos DMM, Chaves GC, Azeredo TB, Silva RM. Política Nacional de Medicamentos em retrospectiva: um balanço de (quase) 20 anos de implementação. Cien Saude Colet 2017; 22(8):2609-2614. [ Links ]

53 Catanheide ID, Lisboa ES, Souza LEPF. Características da judicialização do acesso a medicamentos no Brasil: uma revisão sistemática. Physis 2016; 26(4):1335-1356. [ Links ]

54 Pepe VLE, Figueiredo TA, Simas L, Osorio-de-Castro CGS, Ventura M. A judicialização da saúde e os novos desafios da gestão da assistência farmacêutica. Cien Saude Colet 2010; 15(5):2405-2414. [ Links ]

55 Santos-Pinto CDB, Ventura M, Pepe VLE, Osorio-de-Castro CGS. Novos delineamentos da Assistência Farmacêutica frente à regulamentação da Lei Orgânica da Saúde. Cad Saúde Pública 2013; 29(6):1056-1058. [ Links ]

56 Santos-Pinto CDB, Costa NR, Osorio-de-Castro CGS. Quem acessa o Programa Farmácia Popular do Brasil? Aspectos do fornecimento público de medicamentos. Cien Saude Colet 2011; 16(6):2963-2973. [ Links ]

57 Pereira MA. Programa farmácia popular no Brasil: uma análise sobre sua relação com o Complexo Econômico-Industrial da Saúde e os programas estratégicos do Governo Federal [dissertação]. Rio de Janeiro: Escola Nacional de Saúde Pública Sérgio Arouca; 2013. [ Links ]

58 Barros SG, Vieira-da-Silva LM. A terapia antirretroviral combinada, a política de controle da Aids e as transformações do Espaço Aids no Brasil dos anos 1990. Saúde Debate 2017; 41(n. esp. 3):114-128. [ Links ]

59 Fedatto MS. Epidemia da AIDS e a Sociedade Moçambicana de Medicamentos: análise da cooperação brasileira. Cien Saude Colet 2017; 22(7):2295-2304. [ Links ]

60 Dubitzky W, Wolkenhauer O, Yokota H, Cho K-H, editores. Encyclopedia of Systems Biology. New York: Springer; 2013. [ Links ]

Received: April 15, 2020; Accepted: June 08, 2020; Published: June 10, 2020


All authors participated in the work in all its stages, including its conception and planning, data collection and analysis, as well as the preparation of the text and figures, and the review and approval of the final version of the manuscript.

Creative Commons License Este é um artigo publicado em acesso aberto sob uma licença Creative Commons